A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/20 (2006.01) A61K 38/17 (2006.01) A61K 38/21 (2006.01) A61K 38/31 (2006.01) A61K 39/395 (2006.01) A61K 45/06 (2006.01) C07K 14/54 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2179183
A method for treating acute pancreatitis comprising administering an effective amount of Interleukin-1 receptor antagonist (IL-1ra) or a pharmaceutically acceptable salt thereof to a person afflicted with that condition.
Un procédé qui permet de traiter la pancréatite aigue, consiste à administrer une dose efficace d'un antagoniste d'un récepteur de l'interleukine-1 (IL-1ra) ou un de ses sels pharmacologiquement acceptables à une personne souffrant de cette maladie.
Borden Ladner Gervais Llp
University Of South Florida
LandOfFree
Interleukin-1 receptor antagonist decreases severity of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Interleukin-1 receptor antagonist decreases severity of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Interleukin-1 receptor antagonist decreases severity of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1930971